VOLPI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.808
EU - Europa 16.482
AS - Asia 15.654
SA - Sud America 2.099
AF - Africa 270
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 34
Totale 69.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.448
GB - Regno Unito 6.123
SG - Singapore 5.097
CN - Cina 5.021
IT - Italia 3.107
HK - Hong Kong 2.078
BR - Brasile 1.658
SE - Svezia 1.604
DE - Germania 1.236
UA - Ucraina 977
TR - Turchia 862
FI - Finlandia 743
RU - Federazione Russa 661
KR - Corea 645
VN - Vietnam 606
FR - Francia 490
BG - Bulgaria 396
IN - India 256
ID - Indonesia 236
NL - Olanda 177
CA - Canada 176
AR - Argentina 168
JP - Giappone 165
PL - Polonia 145
ES - Italia 134
MX - Messico 131
IE - Irlanda 96
CH - Svizzera 91
BD - Bangladesh 81
ZA - Sudafrica 74
AU - Australia 70
IR - Iran 67
IQ - Iraq 66
BE - Belgio 60
PK - Pakistan 60
TH - Thailandia 57
MY - Malesia 56
LT - Lituania 53
GR - Grecia 51
PE - Perù 50
AT - Austria 49
EC - Ecuador 47
CL - Cile 46
CO - Colombia 43
RO - Romania 41
CZ - Repubblica Ceca 40
EG - Egitto 40
VE - Venezuela 39
MA - Marocco 36
UZ - Uzbekistan 35
PT - Portogallo 33
IL - Israele 31
TN - Tunisia 31
RS - Serbia 30
TW - Taiwan 29
DZ - Algeria 28
SK - Slovacchia (Repubblica Slovacca) 28
DK - Danimarca 27
AE - Emirati Arabi Uniti 26
SA - Arabia Saudita 26
EU - Europa 25
PH - Filippine 23
PY - Paraguay 20
KE - Kenya 19
NZ - Nuova Zelanda 18
QA - Qatar 16
HU - Ungheria 15
KZ - Kazakistan 14
UY - Uruguay 14
AL - Albania 13
AZ - Azerbaigian 13
BO - Bolivia 13
NO - Norvegia 12
SI - Slovenia 12
HR - Croazia 11
JO - Giordania 11
LB - Libano 11
CR - Costa Rica 9
BH - Bahrain 8
NG - Nigeria 8
AM - Armenia 7
JM - Giamaica 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
ET - Etiopia 6
HN - Honduras 6
PA - Panama 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
KG - Kirghizistan 5
KH - Cambogia 5
MK - Macedonia 5
MO - Macao, regione amministrativa speciale della Cina 5
NP - Nepal 5
UG - Uganda 5
AO - Angola 4
CU - Cuba 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GT - Guatemala 4
Totale 69.368
Salva come PNG Salva come JPEG
Città #
Southend 4.419
Singapore 3.550
Fairfield 3.402
Santa Clara 3.386
Ashburn 2.651
Woodbridge 2.606
Chandler 2.100
Houston 2.068
Hong Kong 2.053
Jacksonville 2.003
Hefei 1.883
Dearborn 1.557
Wilmington 1.221
Seattle 1.220
Ann Arbor 1.185
Cambridge 1.102
London 955
Nyköping 950
Beijing 860
Los Angeles 508
Seoul 451
Modena 443
Princeton 414
New York 410
Chicago 381
Sofia 378
Helsinki 370
Izmir 368
Eugene 356
San Diego 332
Council Bluffs 314
The Dalles 307
Buffalo 291
Milan 274
Redwood City 220
Moscow 209
Ho Chi Minh City 205
Jakarta 163
Shanghai 157
Salt Lake City 152
Hanoi 143
Columbus 137
Rome 134
São Paulo 130
Des Moines 124
San Jose 108
Dallas 104
Tokyo 98
Munich 91
Bologna 85
Falls Church 84
Dong Ket 80
Dublin 79
Falkenstein 76
Tampa 74
Naples 71
Frankfurt am Main 70
Kent 63
Toronto 63
Elk Grove Village 62
Guangzhou 61
Istanbul 60
Norwalk 60
Amsterdam 57
Boardman 57
Paris 57
Lesquin 55
Nanjing 55
Turku 54
Brooklyn 52
Rio de Janeiro 50
Warsaw 50
Atlanta 49
Brussels 48
Phoenix 48
Madrid 47
Belo Horizonte 45
Florence 45
Kunming 45
San Francisco 44
Sterling 44
Jinan 43
Stockholm 42
Nuremberg 41
Redondo Beach 41
Leipzig 40
Zhengzhou 40
Bangkok 36
Boston 35
Buenos Aires 35
Curitiba 35
Turin 35
Brasília 34
Parma 34
Verona 34
Kilburn 32
Reggio Emilia 32
Chennai 31
Changsha 30
Johannesburg 30
Totale 49.513
Salva come PNG Salva come JPEG
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 1.080
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 635
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 554
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 545
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 458
A 96-well assay for uronic acid carbazole reaction 428
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 407
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 381
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 374
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 367
Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum 341
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 326
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 316
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 309
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 308
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 303
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 302
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 297
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 294
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 292
Purification and characterization of heparin from the Italian clam Callista chione 287
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 286
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 283
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 283
Chondroitin sulfate. Structure, role and pharmacological activity. Nicola Volpi (Editor) 283
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 283
Electrophoretic approaches to the analysis of complex polysaccharides 281
Therapeutic applications of glycosaminoglycans 280
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 276
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 273
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 273
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 271
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 268
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 268
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 267
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 267
The protein profile of fibroblasts: the role of proteomics. 267
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 265
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 265
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 262
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 261
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 260
Glycosaminoglycan content in term and preterm milk during the first month of lactation 259
Composition and structure elucidation of human milk glycosaminoglycans 258
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 256
Recent advances on separation and characterization of human milk oligosaccharides. 255
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 254
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 254
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 253
Comparative analysis of fatty acid profile in three eutardigrade species 253
Glycosaminoglycan composition of the large freshwater mollusc bivalve Anodonta anodonta 250
Capillary electrophoresis of bacterial (lipo)polysaccharides 250
Isolation and structural characterization of chondroitin sulfate from bony fishes 249
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 248
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 247
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 245
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 245
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 244
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 244
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 242
1H and 13C Characterization of Chondroitin Sulphate from Porcine Trachea and Shark Cartilage 242
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 241
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 240
Electrophoresis for the analysis of heparin purity and quality. 240
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 240
Capillary electrophoresis of complex natural polysaccharides 239
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 239
Analytical aspects of pharmaceutical grade chondroitin sulfates 239
Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers 238
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 238
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 237
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 236
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 236
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 234
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 232
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 232
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 231
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 230
Activity of chondroitin ABC lyase and hyaluronidase on free-radical degraded chondroitin sulfate 230
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 227
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 226
1H and 13C Characterization of Chondroitin Sulphate from Beef Trachea 225
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 225
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 224
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 224
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 224
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 223
Anti-zika virus and anti-usutu virus activity of human milk and its components 223
Regulation of arylsulphatases: inhibition of arylsulphatase from Haliotis rufusensis by phosphoric esters and shift of optimal pH depending on temperature 222
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 221
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations 220
Structural characterization of chondroitin sulfate from sturgeon bone 219
Adenylate pool and energy charge in human lymphocytes and granulocytes irradiated at 632 nm (HeNe laser) 219
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 218
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 218
Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography 217
I glicosaminoglicani: struttura, funzioni, tecniche analitiche di indagine, e loro modificazioni in valvole mitraliche ed aortiche di soggetti affetti da patologia degenerativa 217
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 216
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 216
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 216
Totale 27.966
Salva come PNG Salva come JPEG
Categoria #
all - tutte 265.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 265.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.380 0 0 0 0 0 825 663 880 358 843 434 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/202513.778 518 194 225 969 2.501 1.889 773 1.092 1.542 898 1.500 1.677
2025/202612.795 1.406 968 2.446 2.445 3.430 2.100 0 0 0 0 0 0
Totale 69.866